Defensin-barbed innate immunity: Clinical associations in the pediatric population

Pediatrics

Volumn 125, Issue 6, 2010, Pages 1237-1247

  Underwood, Mark A ^a   Bevins, Charles L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acne; Atopic dermatitis; Cystic fibrosis; Defensin; HIV transmission; Infectious diarrhea; Inflammatory bowel disease; Innate immunity; Necrotizing enterocolitis; Otitis media; Psoriasis

Indexed keywords

ALPHA DEFENSIN; ANTIBIOTIC AGENT; BACTERIAL TOXIN; BETA DEFENSIN; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHOLERA TOXIN; CYTOLYSIN; DEFENSIN; INTERLEUKIN 17; MESSENGER RNA; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 9; VIRULENCE FACTOR;

ACNE; ACNE VULGARIS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLERGIC RHINITIS; ANTIMICROBIAL ACTIVITY; ATOPIC DERMATITIS; CANDIDIASIS; CD4+ T LYMPHOCYTE; CHANNEL GATING; CHEMOTAXIS; CHRONIC SINUSITIS; CROHN DISEASE; CYSTIC FIBROSIS; DENTAL CARIES; GASTRITIS; GENE DOSAGE; GENE EXPRESSION; HELICOBACTER PYLORI; HELPER CELL; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DIARRHEA; INNATE IMMUNITY; INTESTINE FLORA; KERATINOCYTE; MORAXELLA CATARRHALIS; NECROTIZING ENTEROCOLITIS; NEWBORN INFECTION; NONHUMAN; OMPHALITIS; OTITIS MEDIA; PATHOPHYSIOLOGY; PERITONSILLAR ABSCESS; PHENOTYPE; PLEIOTROPY; PNEUMONIA; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PSORIASIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN ABSCESS; SKIN FLORA; STAPHYLOCOCCUS AUREUS; VERNIX CASEOSA; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ACNE VULGARIS; ANIMALS; BETA-DEFENSINS; CANDIDIASIS; CHILD; CYSTIC FIBROSIS; DEFENSINS; DENTAL CARIES; DERMATITIS, ATOPIC; DIARRHEA; ENTEROCOLITIS, NECROTIZING; EPITHELIAL CELLS; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, INNATE; OTITIS MEDIA; PANETH CELLS; PHAGOCYTOSIS; PSORIASIS;

EID: 77953072318     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-3289     Document Type: Review

References (90)

1. Huttner KM, Bevins CL. Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res. 1999;45(6):785-794
2. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003; 3(9):710-720 (Pubitemid 41070812)
3. Lehrer RI. Primate defensins. Nat Rev Microbiol. 2004;2(9):727-738
4. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002; 415(6870):389-395
5. Salnikov ES, Mason AJ, Bechinger B. Membrane order perturbation in the presence of antimicrobial peptides by (2)H solid-state NMR spectroscopy. Biochimie. 2009; 91(6):734-743
6. Salzman NH, Underwood MA, Bevins CL. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol. 2007;19(2):70-83
7. Salzman NH, Hung K, Haribhai D, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol. 2010;11(1):76-83
8. Lehrer RI, Jung G, Ruchala P, et al. Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins. Infect Immun. 2009;77(9):4028-4040
9. Kim C, Gajendran N, Mittrucker HW, et al. Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc Natl Acad Sci USA. 2005;102(13):4830-4835
10. Kim C, Slavinskaya Z, Merrill AR, Kaufmann SH. Human alpha-defensins neutralize toxins of the mono-ADP-ribosyltransferase family. Biochem J. 2006;399(2):225-229
11. Giesemann T, Guttenberg G, Aktories K. Human alpha-defensins inhibit Clostridium difficile toxin B. Gastroenterology. 2008; 134(7):2049-2058
12. Yang D, Liu ZH, Tewary P, Chen Q, de la Rosa G, Oppenheim JJ. Defensin participation in innate and adaptive immunity. Curr Pharm Des. 2007;13(30):3131-3139
13. Hollox EJ, Barber JC, Brookes AJ, Armour JA. Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1. Genome Res. 2008;18(11):1686-1697
14. Abu Bakar S, Hollox EJ, Armour JA. Allelic recombination between distinct genomic locations generates copy number diversity in human beta-defensins. Proc Natl Acad Sci USA. 2009;106(3):853-858
15. Linzmeier RM, Ganz T. Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics. 2005;86(4):423-430 (Pubitemid 43293155)
16. Gloor M, Peters G, Stoika D. On the resident aerobic bacterial skin flora in unaffected skin of patients with atopic dermatitis and in healthy controls. Dermatologica. 1982; 164(4):258-265 (Pubitemid 12155235)
17. Dekio I, Sakamoto M, Hayashi H, Amagai M, Suematsu M, Benno Y. Characterization of skin microbiota in patients with atopic dermatitis and in normal subjects using 16S rRNA gene-based comprehensive analysis. J Med Microbiol. 2007;56(pt 12):1675-1683 (Pubitemid 350276519)
18. Penders J, Thijs C, van den Brandt PA, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut. 2007; 56(5):661-667 (Pubitemid 46662932)
19. Wang M, Karlsson C, Olsson C, et al. Reduced diversity in the early fecal microbiota of infants with atopic eczea J Allergy Clin Immunol. 2008;121(1):129-134
20. Isolauri E. Dietary modification of atopic disease: use of probiotics in the prevention of atopic dermatitis. Curr Allergy Asthma Rep. 2004;4(4):270-275 (Pubitemid 39359528)
21. Dotterud LK, Wilsgaard T, Vorland LH, Falk ES. The effect of UVB radiation on skin microbiota in patients with atopic dermatitis and healthy controls. Int J Circumpolar Health. 2008;67(2-3):254-260
22. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347(15):1151-1160
23. Howell MD, Fairchild HR, Kim BE, et al. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol. 2008;128(9):2248-2258
24. Prado-Montes de Oca E, Garcia-Vargas A, Lozano-Inocencio R, et al. Association of beta-defensin 1 single nucleotide polymorphisms with atopic dermatitis. Int Arch Allergy Immunol. 2007;142(3):211-218 (Pubitemid 46272369)
25. Kisich KO, Carspecken CW, Fieve S, Boguniewicz M, Leung DY. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol. 2008;122(1):62-68
26. Asano S, Ichikawa Y, Kumagai T, Kawashima M, Imokawa G. Microanalysis of an antimicrobial peptide, beta-defensin-2, in the stratum corneum from patients with atopic dermatitis. Br J Dermatol. 2008;159(1):97-104 (Pubitemid 351874497)
27. Harder J, Dressel S, Wittersheim M, et al. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol. 2010; In press
28. Harder J, Glaser R, Schroder JM. The role and potential therapeutical applications of antimicrobial proteins in infectious and inflammatory diseases. Endocr Metab Immune Disord Drug Targets. 2007;7(2):75-82
29. Gilliet M, Lande R. Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr Opin Immunol. 2008;20(4): 401-407
30. Hollox EJ, Huffmeier U, Zeeuwen PL, et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet. 2008;40(1):23-25
31. Jansen PA, Rodijk-Olthuis D, Hollox EJ, et al. Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin. PLoS ONE. 2009;4(3): e4725
32. 3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173(5): 2909-2912
33. Trivedi NR, Gilliland KL, Zhao W, Liu W, Thiboutot DM. Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J Invest Dermatol. 2006; 126(5):1071-1079
34. Chronnell CM, Ghali LR, Ali RS, et al. Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J Invest Dermatol. 2001; 117(5):1120-1125
35. Nagy I, Pivarcsi A, Koreck A, Szell M, Urban E, Kemeny L. Distinct strains of Propionibacterium acnes induce selective human beta-defensin- 2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J Invest Dermatol. 2005;124(5): 931-938
36. Nagy I, Pivarcsi A, Kis K, et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/ chemokines in human sebocytes. Microbes Infect. 2006;8(8):2195-2205
37. Tollin M, Bergsson G, Kai-Larsen Y, et al. Vernix caseosa as a multi-component defence system based on polypeptides, lipids and their interactions. Cell Mol Life Sci. 2005; 62(19-20):2390-2399
38. Tollin M, Jagerbrink T, Haraldsson A, Agerberth B, Jornvall H. Proteome analysis of vernix caseosa. Pediatr Res. 2006;60(4): 430-434
39. Oudshoorn MH, Rissmann R, van der Coelen D, Hennink WE, Ponec M, Bouwstra JA. Effect of synthetic vernix biofilms on barrier recovery of damaged mouse skin. Exp Dermatol. 2009;18(8):695-703
40. Rissmann R, Oudshoorn MH, Zwier R, Ponec M, Bouwstra JA, Hennink WE. Mimicking vernix caseosa: preparation and characterization of synthetic biofilms. Int J Pharm. 2009; 372(1-2):59-65
41. Wehkamp J, Salzman NH, Porter E, et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA. 2005;102(50):18129-18134
42. Wehkamp J, Wang G, Kubler I, et al. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol. 2007;179(5):3109-3118
43. Kusek K, Punati J, Bevins CL, et al. Human alpha defensin 5 mRNA levels are decreased in children with untreated, newly diagnosed Crohn disease. Gastroenterology. 2009;136(5):A-14
44. Perminow G, Beisner J, Koslowski M, et al. Defective Paneth cell-mediated host defense in pediatric ileal Crohn's disease. Am J Gastroenterol. 2010;105(2):452-459
45. Wehkamp J, Schmid M, Stange EF. Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr Opin Gastroenterol. 2007;23(4):370-378
46. Fellermann K, Stange DE, Schaeffeler E, et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet. 2006;79(3): 439-448
47. Bentley RW, Pearson J, Gearry RB, et al. Association of higher DEFB4 genomic copy number with Crohn's disease. Am J Gastroenterol. 2010;105(2):354-359
48. Coutinho HB, da Mota HC, Coutinho VB, et al. Absence of lysozyme (muramidase) in the intestinal Paneth cells of newborn infants with necrotising enterocolitis. J Clin Pathol. 1998;51(7):512-514
49. Schaart MW, de Bruijn AC, Bouwman DM, et al. Epithelial functions of the residual bowel after surgery for necrotising enterocolitis in human infants. J Pediatr Gastroenterol Nutr. 2009;49(1):31-41
50. Salzman NH, Polin RA, Harris MC, et al. Enteric defensin expression in necrotizing enterocolitis. Pediatr Res. 1998;44(1):20-26
51. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature. 2003; 422(6931):522-526
52. Brandl K, Plitas G, Schnabl B, DeMatteo RP, Pamer EG. MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J Exp Med. 2007; 204(8):1891-1900
53. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci USA. 2008; 105(52):20858-20863
54. Kelly P, Bajaj-Elliott M, Katubulushi M, et al. Reduced gene expression of intestinal alpha-defensins predicts diarrhea in a cohort of African adults. J Infect Dis. 2006; 193(10):1464-1470
55. Wilson CL, Ouellette AJ, Satchell DP, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science. 1999; 286(5437):113-117
56. Sherman MP, Bennett SH, Hwang FF, Sherman J, Bevins CL. Paneth cells and antibacterial host defense in neonatal small intestine. Infect Immun. 2005;73(9):6143-6146
57. Zilbauer M, Dorrell N, Boughan PK, et al. Intestinal innate immunity to Campylobacter jejuni results in induction of bactericidal human beta-defensins 2 and 3. Infect Immun. 2005;73(11):7281-7289
58. Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol. 2006; 4(7):529-536
59. Heesemann J, Sing A, Trulzsch K. Yersinia's stratagem: targeting innate and adaptive immune defense. Curr Opin Microbiol. 2006; 9(1):55-61
60. Islam D, Bandholtz L, Nilsson J, et al. Down-regulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med. 2001;7(2):180-185 (Pubitemid 32148484)
61. Sperandio B, Regnault B, Guo J, et al. Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J Exp Med. 2008;205(5): 1121-1132 (Pubitemid 351679687)
62. Chakraborty K, Ghosh S, Koley H, et al. Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells. Cell Microbiol. 2008;10(12):2520-2537
63. Soylu OB, Ozturk Y, Ozer E. Alpha-defensin expression in the gastric tissue of children with Helicobacter pylori-associated chronic gastritis: an immunohistochemical study. J Pediatr Gastroenterol Nutr. 2008;46(4): 474-477 (Pubitemid 351457891)
64. Isomoto H, Mukae H, Ishimoto H, et al. High concentrations of human beta-defensin 2 in gastric juice of patients with Helicobacter pylori infection. World J Gastroenterol. 2005;11(31):4782-4787 (Pubitemid 41223283)
65. Isomoto H, Mukae H, Ishimoto H, et al. Elevated concentrations of alpha-defensins in gastric juice of patients with Helicobacter pylori infection. Am J Gastroenterol. 2004; 99(10):1916-1923 (Pubitemid 39421233)
66. Hamanaka Y, Nakashima M, Wada A, et al. Expression of human beta-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori. Gut. 2001;49(4):481-487
67. Hornsby MJ, Huff JL, Kays RJ, Canfield DR, Bevins CL, Solnick JV. Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity islanddependent manner. Gastroenterology. 2008;134(4):1049- 1057
68. Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA. Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol. 2003;41(1):90-96
69. Zaoutis TE, Heydon K, Localio R, Walsh TJ, Feudtner C. Outcomes attributable to neo-natal candidiasis. Clin Infect Dis. 2007;44(9): 1187-1193
70. Komatsuzawa H, Ouhara K, Kawai T, et al. Susceptibility of periodontopathogenic and cariogenic bacteria to defensins and potential therapeutic use of defensins in oral diseases. Curr Pharm Des. 2007;13(30):3084-3095
71. Song W, Shi Y, Xiao M, et al. In vitro bactericidal activity of recombinant human beta-defensin- 3 against pathogenic bacterial strains in human tooth root canal. Int J Antimicrob Agents. 2009;33(3):237-243
72. Carlsson G, Andersson M, Putsep K, et al. Kostmann syndrome or infantile genetic agranulocytosis, part one: celebrating 50 years of clinical and basic research on severe congenital neutropenia. Acta Paediatr. 2006;95(12):1526-1532
73. Dale BA, Tao R, Kimball JR, Jurevic RJ. Oral antimicrobial peptides and biological control of caries. BMC Oral Health. 2006;6(suppl 1):S13
74. Bakaletz LO. Immunopathogenesis of polymicrobial otitis media. J Leukoc Biol. 2010;87(2):213-222
75. Lee HY, Andalibi A, Webster P, et al. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis, and nontypeable Haemophilus influenzae. BMC Infect Dis. 2004;4:12
76. Jin Shin D, Gan-Undram S, Jin Kim S, Joon Jun Y, Jung Im G, Hyun Jung H. Expression of beta-defensins in the tubotympanum of experimental otitis media. Acta Otolaryngol. 2006;126(10):1040-1045
77. Moon SK, Lee HY, Pan H, et al. Synergistic effect of interleukin 1 alpha on nontypeable Haemophilus influenzae-induced up-regulation of human beta-defensin 2 in middle ear epithelial cells. BMC Infect Dis. 2006;6:12
78. Bakaletz LO. Chinchilla as a robust, reproducible and polymicrobial model of otitis media and its prevention. Expert Rev Vaccines. 2009;8(8):1063-1082
79. McGillivary G, Mason KM, Jurcisek JA, Peeples ME, Bakaletz LO. RSV-induced dys-regulation of expression of a mucosal beta-defensin augments colonization of the upper airway by nontypeable Haemophilus influenzae. Cell Microbiol. 2009;11(9): 1399-1408
80. Tesse R, Cardinale F, Santostasi T, et al. Association of beta-defensin-1 gene polymorphisms with Pseudomonas aeruginosa airway colonization in cystic fibrosis. Genes Immun. 2008;9(1):57-60
81. Voglis S, Quinn K, Tullis E, et al. Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs. Am J Respir Crit Care Med. 2009;180(2):159-166
82. Benincasa M, Mattiuzzo M, Herasimenka Y, Cescutti P, Rizzo R, Gennaro R. Activity of antimicrobial peptides in the presence of polysaccharides produced by pulmonary pathogens. J Pept Sci. 2009;15(9): 595-600
83. Herr C, Shaykhiev R, Bals R. The role of cathelicidin and defensins in pulmonary inflammatory diseases. Expert Opin Biol Ther. 2007;7(9):1449-1461
84. Schwaab M, Hansen S, Pearson MD, Shagdarsuren S, Dazert S. Human beta-defensins: at the front line of the peritonsillar abscess. Eur J Clin Microbiol Infect Dis. 2009;28(7):745-755
85. Kalfa VC, Spector SL, Ganz T, Cole AM. Lysozyme levels in the nasal secretions of patients with perennial allergic rhinitis and recurrent sinusitis. Ann Allergy Asthma Immunol. 2004;93(3):288-292 (Pubitemid 39294735)
86. Ooi EH, Wormald PJ, Tan LW. Innate immunity in the paranasal sinuses: a review of nasal host defenses. Am J Rhinol. 2008; 22(1):13-19
87. Ricci E, Malacrida S, Zanchetta M, Montagna M, Giaquinto C, De Rossi A. Role of beta-defensin-1 polymorphisms in mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr. 2009;51(1): 13-19
88. Milanese M, Segat L, Arraes LC, Garzino- Demo A, Crovella S. Copy number variation of defensin genes and HIV infection in Brazilian children. J Acquir Immune Defic Syndr. 2009;50(3):331-333
89. Schumann A, Nutten S, Donnicola D, et al. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol Genomics. 2005;23(2): 235-245 (Pubitemid 44437982)
90. Möndel M, Schroeder BO, Zimmermann K, et al. Probiotic E coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol. 2009;2(2):166-172